KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mgp Ingredients (MGPI) Cash from Investing Activities (2016 - 2025)

Mgp Ingredients (MGPI) has disclosed Cash from Investing Activities for 16 consecutive years, with -$4.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities rose 73.76% to -$4.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$45.5 million, a 36.38% increase, with the full-year FY2025 number at -$45.5 million, up 36.38% from a year prior.
  • Cash from Investing Activities was -$4.8 million for Q4 2025 at Mgp Ingredients, up from -$8.5 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $6.5 million in Q4 2021 to a low of -$156.9 million in Q2 2021.
  • A 5-year average of -$25.3 million and a median of -$12.9 million in 2021 define the central range for Cash from Investing Activities.
  • Biggest YoY gain for Cash from Investing Activities was 258.37% in 2021; the steepest drop was 3619.65% in 2021.
  • Mgp Ingredients' Cash from Investing Activities stood at $6.5 million in 2021, then tumbled by 345.14% to -$16.0 million in 2022, then rose by 21.79% to -$12.6 million in 2023, then tumbled by 46.85% to -$18.4 million in 2024, then skyrocketed by 73.76% to -$4.8 million in 2025.
  • Per Business Quant, the three most recent readings for MGPI's Cash from Investing Activities are -$4.8 million (Q4 2025), -$8.5 million (Q3 2025), and -$12.2 million (Q2 2025).